Parallax Volatility Advisers’s Medifast MED Stock Holding History

Parallax Volatility Advisers’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-60,000	Closed	-$7.7M	–	3011
2019 Q2	$7.7M	Buy	+60,000	New	+$8.34M	0.01%	590
2017 Q1	–	Sell	-1,500	Closed	-$62K	–	4223
2016 Q4	$62K	Buy	+1,500	New	+$60.4K	﹤0.01%	2394
2015 Q2	–	Sell	-500	Closed	-$15K	–	4420
2015 Q1	$15K	Sell	500 -7,900	-94%	-$251K	﹤0.01%	3749
2014 Q4	$283K	Buy	8,400 +1,600	+24%	+$49.8K	﹤0.01%	2535
2014 Q3	$223K	Buy	6,800 +2,300	+51%	+$70.6K	﹤0.01%	2389
2014 Q2	$137K	Sell	4,500 -8,800	-66%	-$274K	﹤0.01%	2273
2014 Q1	$389K	Buy	+13,300	New	+$356K	﹤0.01%	1126
2013 Q3	–	Sell	-1,000	Closed	-$26K	–	3150
2013 Q2	$26K	Buy	+1,000	New	+$26.3K	﹤0.01%	1881

Other funds holding MED

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Parallax Volatility Advisers's MED Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Medifast (MED) in Q4 2018, closing a stake of 25 shares — an estimated $6K sold.

Parallax Volatility Advisers first reported a position in MED in Q3 2013 and held it in 8 quarters. The position peaked at $111K in Q4 2017. 247 funds tracked by Wall St. Rank hold MED as of Q4 2018.

Parallax Volatility Advisers reported no remaining Medifast position as of Q4 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 25 Medifast shares in Q4 2018, an estimated $6K.
Parallax Volatility Advisers first reported a position in Medifast in Q3 2013 and held it in 8 quarters.
Parallax Volatility Advisers's Medifast position peaked at $111K in Q4 2017.
247 funds tracked by Wall St. Rank held Medifast as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.